SCHEMBL24313680

SCHEMBL24313680

CC(C)c1ccc(OCC(F)(F)F)c([S+]([O-])NC(=O)c2cc3c(F)cc(C4CC4)cc3o2)c1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.39
MCHR1 Q99705 1/20 0.39
CNR2 P34972 13/20 0.34
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
LMNA P02545 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313682 0.91 ALDH1A1 (0.34) KCNH2MCHR1ALDH1A1CYP1A2CYP2C9
SCHEMBL24314223 0.90 PDE4A (0.34) KCNH2MCHR1CNR2
SCHEMBL24313763 0.89 KCNH2 (0.39) KCNH2MCHR1CNR2ALDH1A1POLB
SCHEMBL24314317 0.89 PDK2 (0.37)
SCHEMBL24314313 0.88 ACACB (0.36)
SCHEMBL24314217 0.86 PDE4D (0.31)
SCHEMBL24314303 0.85 MEN1 (0.35) KCNH2MCHR1ALDH1A1POLBCYP1A2
SCHEMBL24313977 0.83 CYP1A2 (0.37) KCNH2MCHR1ALDH1A1CYP1A2CYP2C9
SCHEMBL24313683 0.82 KCNH2 (0.40) KCNH2MCHR1CNR2ALDH1A1CACNA1G
SCHEMBL24314235 0.81 KCNH2 (0.36) KCNH2MCHR1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed